​

Aprea Therapeutics Ownership | Who Owns Aprea Therapeutics?

OverviewForecastRevenueFinancialsChart

Aprea Therapeutics Ownership Summary

Aprea Therapeutics is owned by 26.61% institutional investors, 10.44% insiders, and 62.95% retail investors. Aigh capital management is the largest institutional shareholder, holding 8.87% of APRE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.67% of its assets in Aprea Therapeutics shares.

APRE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAprea Therapeutics26.61%10.44%62.95%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Aigh capital management539.30K8.87%$795.47K
Sphera funds management270.00K4.44%$398.25K
Nantahala capital management205.76K3.38%$303.50K
Vanguard group158.24K2.60%$233.40K
Dafna capital management137.17K2.25%$202.33K
Sio capital management112.22K1.84%$165.53K
Morgan stanley65.81K1.08%$97.07K
Geode capital management44.62K0.73%$65.82K
Bnp paribas arbitrage, snc17.13K0.28%$25.27K
Lpl financial16.05K0.26%$23.68K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management539.30K0.22%$795.47K
Sphera funds management270.00K0.08%$398.25K
Dafna capital management137.17K0.05%$202.33K
Sio capital management112.22K0.04%$165.53K
Nantahala capital management205.76K0.01%$303.50K
Landscape capital management10.50K0.00%$15.48K
Mb, levis & associates806.000.00%$1.19K
Wealthcollab158.000.00%$234.00
Hrt financial lp12.26K0.00%$18.00K
Advisor group400.00-$609.00

Top Buyers

HolderShares% AssetsChange
Hrt financial lp12.26K0.00%12.26K
Morgan stanley65.81K-2.48K
Bnp paribas arbitrage, snc17.13K-1.70K
Geode capital management44.62K-1.48K
Citigroup5.00-5.00

Top Sellers

HolderShares% AssetsChange
Sio capital management112.22K0.04%-167.15K
Stonepine capital management---102.24K
Exome asset management---28.97K
Vanguard group158.24K--15.60K
Dimensional fund advisors lp---14.46K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp12.26K0.00%12.26K$18.00K
Citigroup5.00-5.00$7.00

Sold Out

HolderChange
Jpmorgan chase-10.00
Princeton global asset management-100.00
Fmr-501.00
Nbc securities-899.00
Dimensional fund advisors lp-14.46K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202523-1,618,851-10.83%262.99%7-12.50%650.00%
Jun 30, 202523-11.54%1,815,208-6.90%292.82%740.00%4-42.86%
Mar 31, 202526-1,949,704-6.15%322.29%5-50.00%775.00%
Dec 31, 20242618.18%2,077,3813.81%373.32%1066.67%433.33%
Sep 30, 20241-899--3302.80%----

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF145.28K2.67%-
Vanguard Total Stock Mkt Idx Inv142.17K2.57%-3.11K
Fidelity Extended Market Index24.24K0.42%-171.00
Vanguard Institutional Extnd Mkt Idx Tr19.62K0.35%-8.94K
DFA US Targeted Value I7.98K0.14%-
Fidelity Total Market Index7.20K0.12%-
Fidelity Series Total Market Index5.85K0.10%-
Dimensional US Targeted Value ETF3.52K0.06%-
Spartan Extended Market Index Pool F3.35K0.06%171.00
Spartan Extended Market Index Pool E2.95K0.05%212.00

Recent Insider Transactions

DateNameRoleActivityValue
Apr 03, 2025Gilad Oren President/CEOBuy$5.62K
Apr 03, 2025Gilad Oren President/CEOBuy$4.49K
Oct 18, 2024Duey Marc-Sell$29.58K
Oct 23, 2024Gilad Oren President/CEOBuy$1.96K
Oct 16, 2024Duey Marc-Buy$131.70K

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1--
2024 Q491
2024 Q2--
2024 Q112-

APRE Ownership FAQ

Who Owns Aprea Therapeutics?

Aprea Therapeutics shareholders are primarily institutional investors at 26.61%, followed by 10.44% insiders and 62.95% retail investors. The average institutional ownership in Aprea Therapeutics's industry, Biotech Stocks , is 45.24%, which Aprea Therapeutics falls below.

Who owns the most shares of Aprea Therapeutics?

Aprea Therapeutics’s largest shareholders are Aigh capital management (539.3K shares, 8.87%), Sphera funds management (270K shares, 4.44%), and Nantahala capital management (205.76K shares, 3.38%). Together, they hold 16.69% of Aprea Therapeutics’s total shares outstanding.

Does Blackrock own Aprea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aprea Therapeutics.

Who is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.22% of its assets in 539.3K Aprea Therapeutics shares, valued at 795.47K$.

Who is the top mutual fund holder of Aprea Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Aprea Therapeutics shares, with 2.67% of its total shares outstanding invested in 145.28K Aprea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools